Fellow of the American Institute of Medical and Biological Engineering
Professor Cui’s AIMBE Fellowship 'is in recognition of outstanding contribution to the field of Medical and Biological Engineering. Zhanfeng Cui, PhD, DS has been elected to a distinguished Fellow of the Institution for outstanding contributions to the development of novel tissue engineering technologies and their commercialisation'.
As Director of the Oxford Centre for Tissue Engineering and Bioprocessing, Professor Cui oversees the development of bioreactor technologies for the growth of bone, cartilage, tendon and neuron cells, and the longer term aim is bulky tissue growth from stem cell cultures. Professor Cui also has research interests in the technologies that will monitor and regulate tissue growth, including micro membrane probes and micro sensors, and in cryo-preservation techniques. A further related area of research is into membrane filtration processes.
Professor Cui’s first degree and doctorate were gained in China, and he has been very active in promoting engineering and scientific collaborations between the UK and China.
He has also founded a spinout company, Zyoxel, which was set up in 2009 to commercialise the development of TissueFlex, a microbioreactor for 3D perfused cell culture, which has attracted funding from a Hong Kong engineering company.
The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organisation headquartered in Washington, D.C., representing 50,000 individuals and the top 2% of medical and biological engineers. In addition, AIMBE represents academic institutions, private industry, and professional engineering societies.